Osteoporosis :: FDA approves Reclast injection for women with postmenopausal osteoporosis
Reclast (zoledronic acid) Injection — the first and only once-yearly medicine for postmenopausal osteoporosis — has been approved by the US Food and Drug Administration FDA.